Bioregenx (BRGX) Notes Payables (2022 - 2023)
Bioregenx (BRGX) posted quarterly Notes Payables of $25370.0 for Q4 2023, down 38.08% year-over-year from $40970.0 in Q4 2022, and up 76.3% quarter-over-quarter from $14390.0 in Q3 2023.
Bioregenx (BRGX) Notes Payables (2022 - 2023) Analysis & Trends
Bioregenx's Notes Payables history runs 2 years deep, the most recent figure standing at $25370.0 for Q4 2023.
- In Q4 2023, Notes Payables fell 38.08% year-over-year to $25370.0; the TTM figure through Dec 2023 stood at $25370.0 (down 38.08% YoY), while the FY2023 annual figure was $25370.0, down 38.08% from the prior year.
- Notes Payables for Q4 2023 stood at $25370.0, up from $14390.0 in the prior quarter.
- The five-year high for Notes Payables was $40970.0 in Q4 2022, with the low at $12590.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 25,370.00 |
| Sep 30, 2023 | 14,390.00 |
| Jun 30, 2023 | 12,590.00 |
| Mar 31, 2023 | 12,590.00 |
| Dec 31, 2022 | 40,970.00 |